In today's episode, Ian King speaks with Dan Ives - managing director of the brokerage and advisory firm Wedbush Securities - to discuss Microsoft's revenues and AI.
Ian Johnston, global pharmaceutical correspondent at the Financial Times, discuses sales of popular weight loss drug 'Wegvoy', made by Novo Nordisk - as they say their sales almost quadrupled last year.
And, Ian discusses GSK's operating profit of £8.8billion for 2023 with strong selling medicines including its HIV and shingles medication.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode